Newsroom
LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation
Investment will help fuel international partnerships, scale production of its early autism diagnostic aid test – StrandDx™ASD – which is expected to become available to …
LinusBio Raises $16 Million to Scale Growth and Deliver Tangible Outcomes
The company set to unveil an early autism and ALS detection and treatment platform New York City – January 13, 2023 – LinusBio, a leader in …
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, today announced the companies are forming a …
LinusBio Recognized at the 2022 Mount Sinai Innovation Awards
Dr. Manish Arora Speaks at the Innovation Awards ceremony. Photo by Monika Graff Contact: mg@monikagraff.com The Biotech Startup, That Developed A Novel Precision Exposome Sequencing …
WATCH: Detecting Autism at Birth and Opportunity for Early Intervention
Watch the webinar: Manish Arora, PhD, Founder, CEO and CSO at Linus Bio, speaks at the Institute for Exposomic Research at Mount Sinai.
WATCH: HITLAB 2021 Innovator’s Summit Presentation
Manish Arora, PHD, Co-Founder of Linus Biotechnology speaks at HITLAB 2021 Innovator’s Summit Presentation.
